The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning
Abstract
Fomepizole (4-methylpyrazole, 4-MP, Antizol) is a potent inhibitor of alcohol dehydrogenase that was approved recently by the US Food and Drug Administration (FDA) for the treatment of ethylene glycol poisoning. Although ethanol is the traditional antidote for ethylene glycol poisoning, it has not been studied prospectively. Furthermore, the FDA has not approved the use of ethanol for this purpose. Case reports and a prospective case series indicate that the intravenous (i.v.) administration of fomepizole every 12 hours prevents renal damage and metabolic abnormalities associated with the conversion of ethylene glycol to toxic metabolites. Currently, there are insufficient data to define the relative role of fomepizole and ethanol in the treatment of ethylene glycol poisoning. Fomepizole has clear advantages over ethanol in terms of validated efficacy, predictable pharmacokinetics, ease of administration, and lack of adverse effects, whereas ethanol has clear advantages over fomepizole in terms of long-term clinical experience and acquisition cost. The overall comparative cost of medical treatment using each antidote requires further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1997) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563659709162569 · Cited by 386
Vestal, R. E., McGuire, E. A., Tobin, J. D., Andres, R., Norris, A. H., & Mezey, E. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977213343 · Cited by 365
Fomepizole for the Treatment of Ethylene Glycol Poisoning
Brent, J., McMartin, K., Phillips, S., Burkhart, K. K., Donovan, J. W., Wells, M., & Kulig, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401102 · Cited by 357
Litovitz, T. L., Klein-Schwartz, W., Dyer, K. S., Shannon, M., Lee, S., & Powers, M. (1998) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(98)90000-6 · Cited by 333
(1997) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563659709162568 · Cited by 323
Clinical Pharmacokinetics of Ethanol
Holford, N. H. G. (1987) · Clinical Pharmacokinetics · doi:10.2165/00003088-198713050-00001 · Cited by 283
Parry, M. F., & Wallach, R. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90780-3 · Cited by 260
Blume, S.-H. (1986) · JAMA · doi:10.1001/jama.256.11.1467 · Cited by 231
Human Liver Alcohol Dehydrogenase: Inhibition by Pyrazole and Pyrazole Analogs.
Li, T.-K., Theorell, H., Larsen, C., Nielsen, P. H., Lindberg, A. A., Jansen, G., Lamm, B., & Samuelsson, B. (1969) · Acta Chemica Scandinavica · doi:10.3891/acta.chem.scand.23-0892 · Cited by 226
Effects of Fasting and Chronic Alcohol Consumption on the First-Pass Metabolism of Ethanol
DiPadova, C., Worner, T. M., Julkunen, R. J. K., & Lieber, C. S. (1987) · Gastroenterology · doi:10.1016/s0016-5085(87)91073-0 · Cited by 219
Cited by
Toxic Alcohol Ingestions: Clinical Features, Diagnosis, and Management
Kraut, J. A., & Kurtz, I. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03220807 · Cited by 398
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Akakpo, J. Y., Ramachandran, A., Duan, L., Schaich, M. A., Jaeschke, M. W., Freudenthal, B. D., Ding, W.-X., Rumack, B. H., & Jaeschke, H. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz077 · Cited by 105
PEG 3350 Administration Is Not Associated with Sustained Elevation of Glycol Levels
Williams, K. C., Rogers, L. K., Hill, I., Barnard, J., & Di Lorenzo, C. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.11.028 · Cited by 27
Metadata
- Authors
- Miller, H., Barceloux, D. G., Krenzelok, E. P., Olson, K., & Watson, W.
- Venue
- Journal of Toxicology: Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 1999-01
- Volume
- 37
- Issue
- 5
- Pages
- 537-560
- ISSN
- 0731-3810 (ISSN-L)
- OpenAlex
- W2998360521
- Cited by
- 335
- References
- 43
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.